Clinical Trial Update: First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating first-line treatment of extensive-stage small-cell lung cancer using chemotherapy combined with a PD-1/PD-L1 inhibitor, followed b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• PD-1/PD-L1 inhibitor (unspecified)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 2 | Status: UNKNOWN